|Johan Lyth, John Carstensen, Ingrid Synnerstad and Christer Lindholm|
Stage-specific direct healthcare costs in patients with cutaneous malignant melanoma
Journal of the European Academy of Dermatology and Venereology, 2016, 30(5), 789-793.
|Caroline Simberg-Danell, Johan Lyth, Eva Mansson-Brahme, Margareta Frohm-Nilsson, John Carstensen, Johan Hansson and Hanna Eriksson|
Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden
International Journal of Cancer, 2016, 139(3), 543-553.
Web of Science® Times Cited: 1
|Johan Lyth, R. Mikiver, K. Nielsen, K. Isaksson and C. Ingvar|
Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register
European Journal of Cancer, 2016, 59, 171-178.
|Johan Lyth, H. Eriksson, J. Hansson, C. Ingvar, M. Jansson, J. Lapins, E. Månsson-Brahme, P. Naredi, U. Stierner, G. Ullenhag, John Carstensen and C. Lindholm|
Trends in cutaneous malignant melanoma in Sweden 1997-2011: Thinner tumours and improved survival among men
British Journal of Dermatology, 2015, 172(3), 700-706.
Web of Science® Times Cited: 7
|Britta Krynitz, Barbro Lundh Rozell, Johan Lyth, Karin E. Smedby and Bernt Lindelof|
Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality
The Journal of American Academy of Dermatology, 2015, 73(1), 106-U190.
Web of Science® Times Cited: 3
|Hanna Eriksson, Johan Lyth, Eva Månsson-Brahme, Margareta Frohm-Nilsson, Christian Ingvar, Christer Lindholm, Peter Naredi, Ulrika Stierner, John Carstensen and Johan Hansson|
Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden
Journal of Clinical Oncology, 2014, 32(13), 1356-1364.
Web of Science® Times Cited: 12
|Johan Lyth, J. Hansson, C. Ingvar, E. Mansson-Brahme, P. Naredi, U. Stierner, G. Wagenius and C. Lindholm|
Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark’s level of invasion: results of a population-based study from the Swedish Melanoma Register
British Journal of Dermatology, 2013, 168(4), 779-786.
Web of Science® Times Cited: 15
|Hanna Eriksson, Johan Lyth, Eva Månsson-Brahme, Margareta Frohm-Nilsson, Christian Ingvar, Christer Lindholm, Peter Naredi, Ulrika Stierner, Gunnar Wagenius, John Carstensen and Johan Hansson|
Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden
European Journal of Cancer, 2013, 49(12), 2705-2716.
Web of Science® Times Cited: 17
|Johan Lyth, Swen-Olof Andersson, Ove Andrén, Jan-Erik Johansson, Per Carlsson and Nosrat Shahsavar|
A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer
Scandinavian Journal of Urology and Nephrology, 2012, 46(1), 19-25.
Web of Science® Times Cited: 2
|Swen-Olof Andersson, Ove Andren, Johan Lyth, Jennifer R Stark, Martin Henriksson, Hans-Olov Adami, Per Carlsson and Jan-Erik Johansson|
Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4)
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45(3), 177-183.
Web of Science® Times Cited: 15
|Ulla Frödin, Sussanne Börjeson, Johan Lyth and Kourosh Lotfi|
A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up
Bone Marrow Transplantation, 2011, 46(10), 1345-1352.
Web of Science® Times Cited: 14
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.